Close Menu
USTaxNews.live – Your Trusted Source for U.S. Tax & Finance Updates
  • Home
  • Audit
  • Finance
  • IRS
  • Legal
  • Tax News
  • Tax preparation
  • Tax Tips
  • USA Accounting
What's Hot

I Turned Down Ph.D. Program for a Startup; the Company Folded Quickly

July 20, 2025

Weight loss drugs could help treat PCOS

July 20, 2025

Grief Over My Grandson’s Sudden Death Redefined Success for Me

July 20, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated

Facebook X (Twitter) Instagram
USTaxNews.live – Your Trusted Source for U.S. Tax & Finance Updates
  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
  • Home
  • Audit
  • Finance
  • IRS
  • Legal
  • Tax News
  • Tax preparation
  • Tax Tips
  • USA Accounting
USTaxNews.live – Your Trusted Source for U.S. Tax & Finance Updates
Home » Space startup Varda raises $187 million to make drugs in orbit
Finance

Space startup Varda raises $187 million to make drugs in orbit

EditorBy EditorJuly 10, 2025No Comments2 Mins Read
Share Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email Copy Link


Pavlo Gonchar | Lightrocket | Getty Images

Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space.

The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. It brought the total capital Varda’s raised to $329 million.

“By expanding, we can support work on more complex molecules and ultimately increase cadence to achieve the turnaround times the pharmaceutical industry expects,” Chief Science Officer Adrian Radocea said in a press release Thursday.

Varda’s main mission is to launch and return drugs made in space. The startup has said the medicines crystallize differently in orbit due to the gravity differences, which would allow it to complete drugs that are currently difficult to manufacture.

In 2024, the space startup’s W-Series 1 capsule received FAA approval to return after successfully creating the drug Ritonavir the previous year.

So far, Varda said the company has been able to complete three space launches. Now, a fourth is in orbit, and the company expects to launch a fifth by the end of the year. Varda’s system uses Rocket Lab’s Photon spacecraft for its operation and adds its manufacturing module and a heatshield-protected capsule.

“With this capital, Varda will continue to increase our flight cadence and build out the pharmaceutical lab that will deliver the world’s first microgravity-enabled drug formulation,” said Varda CEO Will Bruey.

Varda Space Industries is the first company to process materials outside the International Space Station.

Recently, the space company has also operated a testbed for the U.S. government to use the W-series reentry vehicles to advance technology.

Varda said it has expanded into Huntsville, Alaska, and opened a laboratory in El Segundo, California, to begin work to crystallize more drugs.

“Our new lab space is an investment in our belief that in-space pharmaceutical manufacturing will drive the foundation of the orbital economy,” Radocea said.



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Editor
  • Website

Related Posts

Weight loss drugs could help treat PCOS

July 20, 2025

International inbound travel to U.S. shows mixed recovery

July 18, 2025

Insurers just marked the costliest first half of the year since 2011

July 18, 2025
Leave A Reply Cancel Reply

News
Finance

Weight loss drugs could help treat PCOS

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.Shelby Knowles |…

International inbound travel to U.S. shows mixed recovery

July 18, 2025

Insurers just marked the costliest first half of the year since 2011

July 18, 2025
Top Trending
IRS

IRS says churches may talk politics without running afoul of tax exempt status

Premium Membership Required

You must be a Premium member to access this content.

Join Now

Already a member? Log in here
IRS

NABA loses sponsors as political climate threatens diversity efforts

Premium Membership Required

You must be a Premium member to access this content.

Join Now

Already a member? Log in here
IRS

The pope took a vow of poverty. He may still need to file US taxes.

Premium Membership Required

You must be a Premium member to access this content.

Join Now

Already a member? Log in here

Subscribe to News

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated

Welcome to USTaxNews.live – Your Trusted Source for U.S. Tax, Accounting, and Financial News.

At USTaxNews.live, we’re committed to delivering accurate, timely, and practical information on everything related to U.S. taxes, IRS updates, legal issues, accounting practices, and the broader financial landscape. Whether you’re a taxpayer, accountant, legal professional, or business owner, we’re here to help you stay informed and ahead of change.

Our Picks

Health care premiums expected to rise for Affordable Care Act enrollees

July 18, 2025

Here’s your potential tax cut in 2026 from the One Big Beautiful Bill Act

July 18, 2025

Senate likely to clear hurdle on Trump’s spending cuts for public broadcasting, foreign aid

July 16, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated

  • Home
  • About Us
  • Advertise With Us
  • Contact Us
  • DMCA
  • Privacy Policy
  • Terms & Conditions
© 2025 ustaxnews. Designed by ustaxnews.

Type above and press Enter to search. Press Esc to cancel.